Budai B - Search Results

1

Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab.

Budai B, Komlósi V, Adleff V, Pap É, Réti A, Nagy T, Kralovánszky J, Láng I, Hitre E. Budai B, et al. Pharmacogenet Genomics. 2012 Jan;22(1):69-72. doi: 10.1097/FPC.0b013e32834d8376. Pharmacogenet Genomics. 2012. PMID: 22044939

2

[Steroid hormone receptors in squamous cell carcinoma of the head and neck].

Budai B, Remenár E, Orosz Z, Számel I, Kralovánszky J, Kásler M. Budai B, et al. Orv Hetil. 1997 Mar 23;138(12):723-7. Orv Hetil. 1997. PMID: 9157342 Hungarian.

3

Influence of hormonal status of patients with cystic disease on the composition of cyst fluid and breast cancer risk.

Budai B, Számel I, Sulyok Z, Németh M, Bak M, Kralovánszky J, Ottó S, Besznyák I, Purohit A, Parish DC, Reed MJ. Budai B, et al. Anticancer Res. 2000 Sep-Oct;20(5C):3879-86. Anticancer Res. 2000. PMID: 11268470

4

Characteristics of cystic breast disease with special regard to breast cancer development.

Budai B, Számel I, Sulyok Z, Német M, Bak M, Ottó S, Reed MJ, Purohit A, Parish DC, Kralovánszky J. Budai B, et al. Anticancer Res. 2001 Jan-Feb;21(1B):749-52. Anticancer Res. 2001. PMID: 11299838

5

Prognostic significance of the thymidylate biosynthetic enzymes in human colorectal tumors.

Kralovánszky J, Köves I, Orosz Z, Katona C, Tóth K, Rahóty P, Czeglédi F, Kovács T, Budai B, Hullán L, Jeney A. Kralovánszky J, et al. Among authors: budai b. Oncology. 2002;62(2):167-74. doi: 10.1159/000048263. Oncology. 2002. PMID: 11914603

6

[Potentiation of 5-fluorouracil efficacy. Molecular mechanisms playing a role in the cytotoxic action of 5-fluorouracil and 5-ethyl-2'-deoxyuridine (EUdR) combination].

Katona C, Timár F, Oláh J, Bocsi J, Budai B, Otvös L, Kralovánszky J. Katona C, et al. Among authors: budai b. Magy Onkol. 2004;48(3):243-51. Epub 2004 Nov 1. Magy Onkol. 2004. PMID: 15520875 Free article. Hungarian.

7

[The clinical importance of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the 5-fluoropyrimidine-based therapy of metastatic colorectal tumours].

Budai B, Hitre E, Adleff V, Czeglédi F, Gyergyay F, Láng I, Kralovánszky J. Budai B, et al. Magy Onkol. 2004;48(3):253-7. Epub 2004 Nov 1. Magy Onkol. 2004. PMID: 15520876 Free article. Hungarian.

8

Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil.

Hitre E, Budai B, Adleff V, Czeglédi F, Horváth Z, Gyergyay F, Lövey J, Kovács T, Orosz Z, Láng I, Kásler M, Kralovánszky J. Hitre E, et al. Among authors: budai b. Pharmacogenet Genomics. 2005 Oct;15(10):723-30. doi: 10.1097/01.fpc.0000175598.42141.59. Pharmacogenet Genomics. 2005. PMID: 16141798

9

[Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].

Kralovánszky J, Adleff V, Hitre E, Pap E, Réti A, Komlósi V, Budai B. Kralovánszky J, et al. Among authors: budai b. Magy Onkol. 2007;51(2):113-25. Epub 2007 Jul 29. Magy Onkol. 2007. PMID: 17660867 Free article. Hungarian.

10

Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population.

Bácsi K, Hitre E, Kósa JP, Horváth H, Lazáry A, Lakatos PL, Balla B, Budai B, Lakatos P, Speer G. Bácsi K, et al. Among authors: budai b. BMC Cancer. 2008 Nov 3;8:317. doi: 10.1186/1471-2407-8-317. BMC Cancer. 2008. PMID: 18980667 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters